User profiles for Yoshiyuki Sugimoto

Yoshiyuki Sugimoto

Scientific Advisor, AbbVie GK, Rheumatology, Medical Affairs, Medical
Verified email at abbvie.com
Cited by 457

12/13 Mediates α1-Adrenergic Receptor–Induced Cardiac Hypertrophy

Y Maruyama, M Nishida, Y Sugimoto… - Circulation …, 2002 - Am Heart Assoc
In neonatal cardiomyocytes, activation of the G q -coupled α 1 -adrenergic receptor (α 1 AR)
induces hypertrophy by activating mitogen-activated protein kinases, including c-Jun NH 2 -…

Chronic alcoholism and evolution of pain and prognosis in chronic pancreatitis

T Hayakawa, T Kondo, T Shibata, Y Sugimoto… - Digestive diseases and …, 1989 - Springer
To evaluate the influence of chronic alcoholism on clinical features of chronic pancreatitis in
Japan, pain evolution, pancreatic insufficiency, and long-term prognosis were studied by …

Discovery of novel 5, 5-diarylpentadienamides as orally available transient receptor potential vanilloid 1 (TRPV1) antagonists

O Saku, H Ishida, E Atsumi, Y Sugimoto… - Journal of Medicinal …, 2012 - ACS Publications
We have developed a novel and potent chemical series of 5,5-diphenylpentadienamides for
targeting TRPV1 in vitro and in vivo. In this investigation, we examined a variety of …

Binding pockets of the β1-and β2-adrenergic receptors for subtype-selective agonists

M Isogaya, Y Sugimoto, R Tanimura, R Tanaka… - Molecular …, 1999 - ASPET
We examined the subtype-selective binding site of the β-adrenergic receptors (βARs). The β
1 /β 2 -chimeric receptors showed the importance of the second and seventh …

Pancreas divisum: A predisposing factor to pancreatitis?

T Hayakawa, T Kondo, T Shibata, Y Sugimoto… - International journal of …, 1989 - Springer
Cases of pancreas divisum (PD) were reviewed in our patients and 19 Japanese and 14
English series during the past 10 yr to see any significant association of PD with certain …

Identification of a key amino acid of the β2-adrenergic receptor for high affinity binding of salmeterol

M Isogaya, Y Yamagiwa, S Fujita, Y Sugimoto… - Molecular …, 1998 - ASPET
Transmembrane domains (TMDs) I, II, and VII of the β 2 -adrenergic receptor (β 2 AR) were
replaced, individually or in combination, with the corresponding regions of the β 1 AR, and …

The therapeutic potential of a novel PSMA antibody and its IL-2 conjugate in prostate cancer

Y Sugimoto, M Hirota, K Yoshikawa… - Anticancer …, 2014 - ar.iiarjournals.org
Prostate-specific membrane antigen (PSMA) is an attractive target for treatment of prostate
cancer. Using the PSMA-recognizing mouse monoclonal antibody 2C9 obtained in our …

Pr1E11, a novel anti-TROP-2 antibody isolated by adenovirus-based antibody screening, recognizes a unique epitope

…, H Misaka, K Myojo, K Nakamura, Y Sugimoto… - Biochemical and …, 2015 - Elsevier
TROP-2 is a type Ⅰ transmembrane glycoprotein that is highly expressed in various
epithelial cancer cells, and its increased expression correlates with poor prognosis. Although …

Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies-related scleroderma renal crisis treated with double-filtration plasmapheresis

A Omote, M Muramatsu, Y Sugimoto, S Hosono… - Internal …, 1997 - jstage.jst.go.jp
A46-year-old female patient whowas diagnosed with systemic sclerosis (SSc) developed
rapidly progressive renal failure without elevation of blood pressure or plasma renin concentra-…

β1-selective agonist (−)-1-(3, 4-dimethoxyphenetylamino)-3-(3, 4-dihydroxy)-2-propanol [(−)-RO363] differentially interacts with key amino acids responsible for β1 …

Y Sugimoto, R Fujisawa, R Tanimura, AL Lattion… - … of Pharmacology and …, 2002 - ASPET
(−)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(−)-RO363] is a highly
selective β 1 -adrenergic receptor (β 1 AR) agonist. To study the binding site of β 1 -selective …